Novita Pharmaceuticals


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Novita Pharmaceuticals is developing new drug molecules to prevent cancer metastasis by targeting a new gene target, fascin.

Novita Pharmaceuticals is developing new drug molecules to prevent cancer metastasis by targeting a new gene target, fascin.

Company (Alive / Active)

Phone: 610-574-8243

Fax:

1161 York Avenue

New York, 10065
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Novita Pharmaceuticals $8.5M Apr 7, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Novita Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compounds and methods for inhibiting fascin Feb 20, 2017 Dec 26, 2017 Patent